Evidence map›Paper›PMID 41268394›Full record

ArticleFrontiers in public health2025

Epidemiological dynamics and molecular characteristics of HIV-1 among transgender women in the Central-West region of Brazil.

Bruno Vinícius Diniz E Silva, Sylvia Lopes Maia Teixeira, Paulie Marcelly Ribeiro Dos Santos, Larissa Silva Magalhães, José Henrique Pilotto, Ingebourg Georg, Carlos Silva de Jesus, Rayana Katylin Mendes Da Silva, Karlla Antonieta Amorim Caetano, Robert Lewis Cook and 4 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Bruno Vinícius Diniz E SilvaInstitute of Tropical Pathology and Public Health, Federal University of Goiás, Goiânia, Goiás, Brazil.
Sylvia Lopes Maia TeixeiraLaboratory of AIDS and Molecular Immunology, Oswaldo Cruz Institute, Rio de Janeiro, Brazil.
Paulie Marcelly Ribeiro Dos SantosPontifical Catholic University of Goiás, Goiânia, Goiás, Brazil.
Larissa Silva MagalhãesPontifical Catholic University of Goiás, Goiânia, Goiás, Brazil.
José Henrique PilottoLaboratory of AIDS and Molecular Immunology, Oswaldo Cruz Institute, Rio de Janeiro, Brazil.
Ingebourg GeorgEvandro Chagas National Institute of Infectious Diseases, Rio de Janeiro, Brazil.
Carlos Silva de JesusLaboratory of AIDS and Molecular Immunology, Oswaldo Cruz Institute, Rio de Janeiro, Brazil.
Rayana Katylin Mendes Da SilvaLaboratory of AIDS and Molecular Immunology, Oswaldo Cruz Institute, Rio de Janeiro, Brazil.
Karlla Antonieta Amorim CaetanoFaculty of Nursing, Federal University of Goiás, Goiânia, Goiás, Brazil.
Robert Lewis CookDepartment of Epidemiology, College of Public Health and Health Professions, and College of Medicine, University of Florida, Gainesville, FL, United States.
Regina Maria Bringel MartinsInstitute of Tropical Pathology and Public Health, Federal University of Goiás, Goiânia, Goiás, Brazil.
Sheila Araujo TelesFaculty of Nursing, Federal University of Goiás, Goiânia, Goiás, Brazil.
Monick Lindenmeyer GuimarãesLaboratory of AIDS and Molecular Immunology, Oswaldo Cruz Institute, Rio de Janeiro, Brazil.
Megmar Aparecida Dos Santos CarneiroInstitute of Tropical Pathology and Public Health, Federal University of Goiás, Goiânia, Goiás, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The human immunodeficiency virus (HIV) epidemic disproportionately affects key populations, including transgender women (TGW). Understanding the epidemiological and molecular characteristics on HIV-1 infection among TGW in Brazil, a continental country, is important to support decisions about public health policies. Therefore, this cross-sectional study aimed to evaluate the HIV prevalence and associated risk factors, recency of infection, genetic diversity of HIV-1, transmission clusters, and drug resistance mutations among TGW in Goiás, a state in the Central-West region of Brazil. Methods: A total of 440 participants from three cities in Goiás (Goiânia, Itumbiara, and Jataí) were recruited using Respondent-Driven Sampling. Serum samples were screened for anti-HIV antibodies using rapid tests and an enzyme-linked immunosorbent assay. Recent acquisitions were identified from plasma samples using the Limiting Antigen Avidity assay. Deoxyribonucleic acid was extracted from blood samples, and the partial polymerase gene (protease/reverse transcriptase region) was amplified using a nested polymerase chain reaction. Sequences were subtyped, analyzed for potential transmission networks, and assessed for drug resistance using the Stanford HIVdb program. Results: Most participants were young, single, self-identified as Black or mixed-race, and had a secondary education level or less. Many reported early sexual debut and multiple high-risk behaviors for sexually transmitted infections. The overall prevalence was 27.3%, with 43.2% classified as recent acquisitions and 56.8% as long-standing. Being over 25 years of age and engaging in chemsex were significantly associated with infection ( Conclusion: These findings underscore the high burden of HIV-1 among TGW in the Central-West region of Brazil and highlight the importance of serological and molecular surveillance in guiding targeted interventions aimed at preventing HIV acquisition and formulating well-informed public health policies for this key population.

Indexed as

HIV-1HIV InfectionsTransgender PersonsAdolescentAdultBrazilCross-Sectional StudiesDrug Resistance, ViralFemaleHumansMaleMiddle AgedPrevalenceRisk FactorsYoung Adultepidemiologygenetic diversityHIV-1sexual behaviortransgender womentransmission network

Identifiers

PMID41268394
PMCPMC12626951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.